AMGEN COMPETITIVE GRANT PROGRAM
 

AMGEN COMPETITIVE GRANT PROGRAM

Amgen is committed to serving the needs of patients facing serious illness. We advance this mission by developing novel therapies and by supporting externally sponsored research.

The Competitive Grant Program provides investigators and scientists with the opportunity to apply for Amgen funding for independent research into mechanisms and impact of specific diseases without focusing on any Amgen product. In this regard, the Competitive Grant Program differs from Investigator Sponsored Studies (ISS) which typically focus on an Amgen product.

The selection process for the Competitive Grant Program is performed by an external, independent review committee in each field utilizing a defined set of criteria.

This website provides information to researchers seeking financial support from Amgen for a study. Qualified health care professionals, scientists, and researchers with promising ideas in areas of mutual scientific interest are invited to review the program requirements and submit an application.

All eligible applications will be reviewed by an independent review committee and awards will be granted on a competitive basis with consideration to the potential for the study to advance science, clinical medicine, and ultimately, patient care.

Once selected, Amgen will contract with grant awardees per Amgen standard contract requirements. Open the following link for details on Amgen’s standard contract requirements.

AVAILABLE COMPETITIVE GRANT PROGRAMS

Select the program below to learn more about the scientific areas of interest and program requirements:

PCSK9 Competitive Grant Program

Applications due by
May 11, 2018

Competitive Grant Program in Migraine Research

Applications due by
Oct 17, 2018


For any questions pertaining specifically to Amgen's Competitive Grant Programs email amgen-scientific-grants@amgen.com